[HTML][HTML] Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day …
J Spona, N Binder, K Höschen, W Feichtinger - Fertility and sterility, 2010 - Elsevier
OBJECTIVE: To describe the suppression of ovarian function with 0.02 mg ethinyl E2–2 mg
chlormadinone acetate administered in a 24/4-day intake regimen in healthy women …
chlormadinone acetate administered in a 24/4-day intake regimen in healthy women …
[引用][C] Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day …
J SPONA, N BINDER, K HÖSCHEN… - Fertility and …, 2010 - pascal-francis.inist.fr
Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg
ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over …
ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over …
Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake …
J Spona, N Binder, K Höschen, W Feichtinger - Fertility and Sterility, 2009 - europepmc.org
Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl
estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three …
estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three …
Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake …
J Spona, N Binder, K Höschen, W Feichtinger - Fertility and Sterility, 2010 - fertstert.org
Objective To describe the suppression of ovarian function with 0.02 mg ethinyl E 2–2 mg
chlormadinone acetate administered in a 24/4-day intake regimen in healthy women …
chlormadinone acetate administered in a 24/4-day intake regimen in healthy women …
Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake …
J Spona, N Binder, K Höschen… - Fertility and …, 2010 - pubmed.ncbi.nlm.nih.gov
Objective To describe the suppression of ovarian function with 0.02 mg ethinyl E (2)-2 mg
chlormadinone acetate administered in a 24/4-day intake regimen in healthy women …
chlormadinone acetate administered in a 24/4-day intake regimen in healthy women …
[PDF][PDF] Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day …
J Spona, N Binder, K Hoschen, W Feichtinger - trials - academia.edu
Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl
estradiol and 2 mg chlormadinone ace Page 1 Suppression of ovarian function by a combined …
estradiol and 2 mg chlormadinone ace Page 1 Suppression of ovarian function by a combined …
Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake …
J Spona, N Binder, K Höschen, W Feichtinger - Fertility and Sterility, 2010 - infona.pl
To describe the suppression of ovarian function with 0.02 mg ethinyl E 2–2 mg
chlormadinone acetate administered in a 24/4-day intake regimen in healthy women. Open …
chlormadinone acetate administered in a 24/4-day intake regimen in healthy women. Open …